Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-23-005058

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Martell Robert Director 2023-02-13 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X03/ownership.xml…